Old Web
English
Sign In
Acemap
>
authorDetail
>
Christine Schulteis
Christine Schulteis
Amylin Pharmaceuticals
Exenatide
Medicine
Endocrinology
Internal medicine
Population
4
Papers
475
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy, Safety, and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus: An Integrated Analysis of the DURATION Trials
2013
Postgraduate Medicine
Michael Grimm
Jenny Han
Carole Weaver
Pete Griffin
Christine Schulteis
Haiying Dong
Jaret Malloy
Show All
Source
Cite
Save
Citations (50)
Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects
2013
British Journal of Clinical Pharmacology
Borje Darpo
Sager Philip
Leigh MacConell
Brenda Cirincione
Malcolm Mitchell
Jenny Han
Wenying Huang
Jaret Malloy
Christine Schulteis
Larry Z. Shen
Lisa Porter
Show All
Source
Cite
Save
Citations (33)
Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP‐1 receptor agonism in patients with type 2 diabetes
2012
Diabetes, Obesity and Metabolism
T. Ridge
T. Moretto
Leigh MacConell
Richard Pencek
Jenny Han
Christine Schulteis
Lisa Porter
Show All
Source
Cite
Save
Citations (25)
DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes.
2011
The Journal of Clinical Endocrinology and Metabolism
Thomas Blevins
John Pullman
Jaret Malloy
Ping Yan
Kristin Taylor
Christine Schulteis
Michael Trautmann
Lisa Porter
Show All
Source
Cite
Save
Citations (367)
1